Effect of SR49059, an orally active V_1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea

Abstract

This study showed for the first time a therapeutic effect of an orally active vasopressin V1a receptor antagonist in the prevention of dysmenorrhoea. Further studies are required to examine effect mechanisms and determine effective doses.